Literature DB >> 34643915

Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulcerans.

Sangeeta Susan Thomas1,2, Nitin Pal Kalia2,3, Kevin Pethe4,5.   

Abstract

Generation and characterization of drug resistant mutants is a powerful tool in antimicrobial drug discovery for identification of the molecular target of an investigational drug candidate. The method is relatively simple to be conducted in a classical microbiology laboratory. Its value has been augmented by the employment of next generation sequencing techniques to characterize single-nucleotide polymorphisms associated with drug resistance. Determination of the frequency of emergence of resistance to drug candidates also provides insights into their usefulness for clinical application. In addition to the generation of drug resistant mutants, we describe a direct method to determine the minimum inhibitory concentration of a drug candidate against Mycobacterium ulcerans.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antimicrobial resistance; Buruli ulcer; Mycobacterium tuberculosis; Resistant mutant selection; Target identification; Turbidity-based MIC

Mesh:

Substances:

Year:  2022        PMID: 34643915     DOI: 10.1007/978-1-0716-1779-3_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

Authors:  H Nikaido
Journal:  Semin Cell Dev Biol       Date:  2001-06       Impact factor: 7.727

Review 2.  Strategies for target identification of antimicrobial natural products.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Prod Rep       Date:  2016-05-04       Impact factor: 13.423

3.  A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana.

Authors:  Marcus Beissner; Nana-Yaa Awua-Boateng; William Thompson; Willemien A Nienhuis; Erasmus Klutse; Pius Agbenorku; Joerg Nitschke; Karl-Heinz Herbinger; Vera Siegmund; Erna Fleischmann; Ohene Adjei; Bernhard Fleischer; Tjip S van der Werf; Thomas Loscher; Gisela Bretzel
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 4.  Appropriate Targets for Antibacterial Drugs.

Authors:  Lynn L Silver
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

Review 5.  Target identification and mechanism of action in chemical biology and drug discovery.

Authors:  Monica Schenone; Vlado Dančík; Bridget K Wagner; Paul A Clemons
Journal:  Nat Chem Biol       Date:  2013-04       Impact factor: 15.040

6.  Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.

Authors:  Laurent Marsollier; Nadine Honoré; Pierre Legras; Anne Lise Manceau; Henri Kouakou; Bernard Carbonnelle; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

7.  Draft Genome Sequence of Mycobacterium ulcerans S4018 Isolated from a Patient with an Active Buruli Ulcer in Benin, Africa.

Authors:  Stanimir Kambarev; Stéphane Corvec; Annick Chauty; Estelle Marion; Laurent Marsollier; Frédéric Pecorari
Journal:  Genome Announc       Date:  2017-04-27

8.  Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer.

Authors:  Nicole Scherr; Raphael Bieri; Sangeeta S Thomas; Aurélie Chauffour; Nitin Pal Kalia; Paul Schneide; Marie-Thérèse Ruf; Araceli Lamelas; Malathy S S Manimekalai; Gerhard Grüber; Norihisa Ishii; Koichi Suzuki; Marcel Tanner; Garrett C Moraski; Marvin J Miller; Matthias Witschel; Vincent Jarlier; Gerd Pluschke; Kevin Pethe
Journal:  Nat Commun       Date:  2018-12-18       Impact factor: 14.919

9.  Complete Genome Sequence of Mycobacterium ulcerans subsp. shinshuense.

Authors:  Mitsunori Yoshida; Kazue Nakanaga; Yoshitoshi Ogura; Atsushi Toyoda; Tadasuke Ooka; Yuko Kazumi; Satoshi Mitarai; Norihisa Ishii; Tetsuya Hayashi; Yoshihiko Hoshino
Journal:  Genome Announc       Date:  2016-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.